Inventor · disambiguated record
David Light
Also filed as: LIGHT DAVID · LIGHT DAVID R · LIGHT DAVID RICHARD
36 granted patents·27 pending applications·678 citations·filing 1983–2025
98Inventor score
Top patents by PatentIndex Score
63 records- 0196US8975302B2Polymer particles, nucleic acid polymer particles and methods of making and using the sameLIGHT DAVID·Filed 2012·Granted Mar 10, 2015·146 cites·20 claims
- 0296US8574835B2Scaffolded nucleic acid polymer particles and methods of making and usingHINZ WOLFGANG·Filed 2010·Granted Nov 5, 2013·34 cites·19 claims
- 0395US9249461B2Scaffolded nucleic acid polymer particles and methods of making and usingLIFE TECHNOLOGIES CORP·Filed 2013·Granted Feb 2, 2016·7 cites·20 claims
- 0492US9315509B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELTAXSYS INC·Filed 2014·Granted Apr 19, 2016·17 cites·20 claims
- 0592US7737145B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseESTRELLITA PHARMACEUTICALS LLC·Filed 2006·Granted Jun 15, 2010·32 cites·10 claims
- 0692US4757012AAscorbic acid intermediates and process enzymesGENENTECH INC·Filed 1984·Granted Jul 12, 1988·48 cites·5 claims
- 0790US11267819B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2020·Granted Mar 8, 2022·2 cites·21 claims
- 0890US8569303B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseARNAIZ DAMIAN O·Filed 2010·Granted Oct 29, 2013·19 cites·12 claims
- 0989US10745680B2Factor IX fusion proteins and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Aug 18, 2020·6 cites·27 claims
- 1089US5008193AAscorbic acid intermediates and process enzymesGENENTECH INC·Filed 1987·Granted Apr 16, 1991·43 cites·12 claims
- 1188US10612017B2Scaffolded nucleic acid polymer particles and methods of making and usingLIFE TECHNOLOGIES CORP·Filed 2018·Granted Apr 7, 2020·1 cites·20 claims
- 1288US10066260B2Matrix arrays and methods for making sameLIFE TECHNOLOGIES CORP·Filed 2014·Granted Sep 4, 2018·4 cites·19 claims
- 1388US5004690AAscorbic acid intermediates and process enzymesGENENTECH INC·Filed 1989·Granted Apr 2, 1991·37 cites·1 claims
- 1488US4758514AAscorbic acid intermediates and process enzymesGENENTECH INC·Filed 1984·Granted Jul 19, 1988·35 cites·14 claims
- 1588US2025296935A1Diamine Derivatives as Inhibitors of Leukotriene A4 HydrolaseCELLTAXIS LLC·Filed 2024·Application pending·0 cites
- 1687US9434805B2Polymer particles, nucleic acid polymer particles and methods of making and using the sameLIFE TECHNOLOGIES CORP·Filed 2015·Granted Sep 6, 2016·2 cites·20 claims
- 1785US4512973AMethod for overcoming trypsin inhibitionGENENTECH INC·Filed 1983·Granted Apr 23, 1985·25 cites·25 claims
- 1884US10738353B2Matrix arrays and methods for making sameLIFE TECHNOLOGIES CORP·Filed 2018·Granted Aug 11, 2020·1 cites·18 claims
- 1984US2024318248A1Device Preparation Using Condensed Nucleic Acid ParticlesLIFE TECHNOLOGIES CORP·Filed 2024·Application pending·0 cites
- 2082US9797011B2Device preparation using condensed nucleic acid particlesLIFE TECHNOLOGIES CORP·Filed 2014·Granted Oct 24, 2017·2 cites·20 claims
- 2181US12173009B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2022·Granted Dec 24, 2024·0 cites·23 claims
- 2281US6632791B1Thrombomodulin analogs for pharmaceutical useSCHERING AG·Filed 2001·Granted Oct 14, 2003·12 cites·16 claims
- 2380US2023175046A1Matrix arrays and methods for making samLIFE TECHNOLOGIES CORP·Filed 2023·Application pending·0 cites
- 2479US12065408B2Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell diseaseUNIV VIRGINIA COMMONWEALTH·Filed 2023·Granted Aug 20, 2024·0 cites·11 claims
- 2577US5863760AProtease-resistant thrombomodulin analogsSCHERING ALTIENGESELLSCHAFT·Filed 1995·Granted Jan 26, 1999·39 cites·17 claims
- 2677US5827824AProtease-resistant thrombomodulin analogsSCHERING AG·Filed 1995·Granted Oct 27, 1998·39 cites·16 claims
- 2777US5256770AOxidation resistant thrombomodulin analogsSCHERING AG·Filed 1990·Granted Oct 26, 1993·54 cites·3 claims
- 2876US12234452B2Scaffolded nucleic acid polymer particles and methods of making and usingLIFE TECHNOLOGIES CORP·Filed 2020·Granted Feb 25, 2025·0 cites·11 claims
- 2976US10221451B2Immobilized buffer particles and uses thereofLIFE TECHNOLOGIES CORP·Filed 2015·Granted Mar 5, 2019·1 cites·20 claims
- 3074US2018179520A1Scaffolded nucleic acid polymer particles and methods of making and usingLIFE TECHNOLOGIES CORP·Filed 2017·Application pending·0 cites
- 3174US2025019349A1Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell diseaseUNIV VIRGINIA COMMONWEALTH·Filed 2024·Application pending·0 cites
- 3273US12006543B2Device preparation using condensed nucleic acid particlesLIFE TECHNOLOGIES CORP·Filed 2021·Granted Jun 11, 2024·0 cites·20 claims
- 3373US11578356B2Matrix arrays and methods for making sameLIFE TECHNOLOGIES CORP·Filed 2020·Granted Feb 14, 2023·0 cites·20 claims
- 3473US5466668ASuperior thrombomodulin analogs for pharmaceutical useSCHERING AG·Filed 1993·Granted Nov 14, 1995·45 cites·26 claims
- 3572US11319587B2Immobilized buffer particles and uses thereofLIFE TECHNOLOGIES CORP·Filed 2019·Granted May 3, 2022·0 cites·20 claims
- 3672US6063763AProtease-resistant thrombomodulin analogsSCHERING AG·Filed 1994·Granted May 16, 2000·24 cites·18 claims
- 3769US2016194629A1Scaffolded nucleic acid polymer particles and methods of making and usingLIFE TECHNOLOGIES CORP·Filed 2016·Application pending·0 cites
- 3867US10533220B2Device preparation using condensed nucleic acid particlesLIFE TECHNOLOGIES CORP·Filed 2017·Granted Jan 14, 2020·0 cites·19 claims
- 3967US9932448B2Purification systems and methodsLIFE TECHNOLOGIES CORP·Filed 2016·Granted Apr 3, 2018·0 cites·17 claims
- 4067US2020149105A1Device preparation using condensed nucleic acid particlesLIFE TECHNOLOGIES CORP·Filed 2020·Application pending·0 cites
- 4165US9890423B2Polymer particles, nucleic acid polymer particles and methods of making and using the sameLIFE TECHNOLOGIES CORP·Filed 2016·Granted Feb 13, 2018·0 cites·19 claims
- 4265US6790828B2Thrombomodulin analogs for pharmaceutical useSCHERING AG·Filed 2003·Granted Sep 14, 2004·2 cites·16 claims
- 4365US2018230159A1Diamine derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2018·Application pending·0 cites
- 4464US2011195459A1Methods of Making Libraries of Nucleic Acids Using Porous ParticlesLIFE TECHNOLOGIES CORP·Filed 2011·Application pending·0 cites
- 4564US2011201508A1Methods of Using Porous ParticlesLIFE TECHNOLOGIES CORP·Filed 2011·Application pending·0 cites
- 4662US2011201506A1Methods of Primer Extension Using Porous Particle SupportsLIFE TECHNOLOGIES CORP·Filed 2011·Application pending·0 cites
- 4762US2011195253A1Scaffolded Nucleic Acid Polymer Particles and Methods of Making and UsingLIFE TECHNOLOGIES CORP·Filed 2011·Application pending·0 cites
- 4862US2011201523A1Particle Arrays and Methods of Making and UsingLIFE TECHNOLOGIES CORP·Filed 2011·Application pending·0 cites
- 4962US2012094871A1Particle Population and Methods of Making and UsingHINZ WOLFGANG·Filed 2011·Application pending·0 cites
- 5061US9534092B2Purification systems and methodsHINZ WOLFGANG·Filed 2012·Granted Jan 3, 2017·1 cites·9 claims
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Light files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →